ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Takeda offers early retirement to workers as young as 30

Japanese drug titan targets non-R&D staff in restructuring push

Takeda acquired Irish biotech Shire  in a 2019 megadeal. It is now looking to refocus and cut expenses. (Photo by Shihoko Nakaoka)

TOKYO -- Takeda Pharmaceutical is offering early retirement to sales staff and other workers in Japan as the drugmaker strategically narrows its focus areas and slims down its workforce.

With a worldwide workforce of about 47,500, Takeda employs 5,350 in Japan, including roughly 2,100 medical representatives. It has been working on restructuring since its January 2019 megadeal to acquire Irish biotech Shire and is moving to specialize in five key business areas, such as oncology and rare diseases.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more